Generic drugs now make up over 90% of U.S. prescriptions, saving billions annually. Their history spans from 19th-century drug standards to the Hatch-Waxman Act and modern supply chain challenges.
Tag: Hatch-Waxman Act
Paragraph IV certifications let generic drug makers challenge brand-name patents before launch, accelerating affordable drug access. Learn how the Hatch-Waxman Act enables this system, why it saves billions, and how companies navigate legal battles over patents.